What to know about the COVID variant that may cause 'razor blade' sore throats
The COVID-19 variant that may be driving a recent rise in cases in some parts of the world has earned a new nickname: 'razor blade throat' COVID.
That's because the variant — NB.1.8.1. or 'Nimbus' — may cause painful sore throats. The symptom has been identified by doctors in the United Kingdom, India and elsewhere, according to media outlets in those countries.
Other COVID-19 symptoms of any variant include fever, chills, cough, shortness of breath or loss of taste or smell.
Experts say there isn't major cause for concern with the Nimbus variant, but here 's what else you need to know about it.
Here's where the variant causing 'razor blade throat' is spreading
The rise in cases late last month is primarily in eastern Mediterranean, Southeast Asia and western Pacific regions, the World Health Organization said May 28. The new variant had reached nearly 11% of sequenced samples reported globally in mid-May.
Airport screening in the United States detected the new variant in travelers arriving from those regions to destinations in California, Washington state, Virginia and New York.
You aren't likely to get sicker from this variant than others
Not so far, anyway.
The WHO said some western Pacific countries have reported increases in COVID cases and hospitalizations, but there's nothing so far to suggest that the disease associated with the new variant is more severe compared to other variants.
COVID-19 vaccines are effective against the Nimbus variant
Yes.
The WHO has designated Nimbus as a 'variant under monitoring' and considers the public health risk low at the global level. Current vaccines are expected to remain effective.
Health Secretary Robert F. Kennedy Jr. announced last month that COVID-19 shots are no longer recommended for healthy children and pregnant women — a move immediately questioned by public health experts.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
2 hours ago
- Business Standard
Younger population seeing high rates infection amid Covid surge: Experts
Waning immunity, delayed testing, social behavior among reasons behind the mild but high infection rate in the 18-45 age group Sanket Koul New Delhi As India confronts a fresh surge in Covid-19 cases, doctors suggest that the virus is disproportionately affecting younger age groups, with the 18 to 45 age bracket facing the brunt of infections. According to data available on the Union Health Ministry's Covid dashboard, India has 5,976 active cases from 29 states and union territories as of 19 June. Of these, Kerala has the highest caseload at 1,309, followed by Gujarat and Delhi at 1,046 and 632 cases respectively. While the government does not provide an age- or gender-wise breakdown of cases, doctors are seeing a noticeable increase in Covid-19 cases among young adults, specifically those aged between 18 and 45. Tushar Tayal, consultant, internal medicine at CK Birla Hospital, Gurugram, said that on average, 10 to 12 patients per day are coming to him with flu-like symptoms and a small but steady percentage of them are testing positive for Covid-19. Aakashneel Bhattacharya, consultant, infectious diseases at Paras Health Gurugram, added that 80 to 85 per cent of Covid patients coming to him fall into the age bracket. Young adults previously considered to be at relatively low risk of severe illness are now presenting with heightened susceptibility, particularly those with a poor follow-up history of vaccination or waning immunity. Divya K S, an infectious disease specialist at Apollo Hospitals Sheshadripuram, Bengaluru, added that the waning immunity over the years, in addition to the emergence of immune-evading strains, makes the younger population more vulnerable. Tayal added that in the 18 to 25 age group, most come with high-grade fever, throat pain, tiredness, body pain, and sometimes gastrointestinal symptoms such as nausea or diarrhoea. Some also complain of a dry cough lasting for days and mild difficulty in breathing. In individuals over 30, symptoms persist longer, and there are more instances of prolonged fatigue or post-viral cough. Commenting on the reasons, Bhattacharya said that younger people are at high risk of contracting the infection as they are the ones who mostly go out and mix with other people in the community. 'Till now, we are not seeing patients developing serious pneumonia or having low oxygen saturation. While few patients may have had minor pneumonia, they are not requiring oxygen,' he added. Tayal, however, added that although most cases of Covid in younger patients are not serious, there needs to be caution against complacency. 'Reinfections are being observed even in persons who have been vaccinated or infected before, pointing to changing viral strains,' he added. Another reason is that many younger patients are delaying getting tested, assuming the infection to be seasonal flu or viral fever. 'Infectious strains that spread faster within a group that is in close contact with each other can result in more case numbers among younger populations, who tend to be at the centre of workplace and social interactions,' Deepesh G Aggarwal, consultant physician and head of department for critical care medicine at Saifee Hospital, Mumbai, added.
India Today
2 hours ago
- India Today
IGNOU, WHO launch healthcare waste management certification, enrolment open
The Indira Gandhi National Open University (IGNOU), in partnership with the World Health Organization (WHO) for the South-East Asia Region, has rolled out a Certificate in Health Care Waste Management (CHCWM). This initiative is poised to bolster public health infrastructures and safeguard the environment by equipping professionals to manage biomedical waste CHCWM programme confronts the dangers to health and ecology posed by inadequate disposal of medical waste. It seeks to educate both professionals and paraprofessionals engaged in hospitals, primary health centres, and waste management sectors. The curriculum aligns with India's Bio-Medical Waste Management Rules, 2016, and adheres to WHO's international AND COURSE STRUCTURECourse enrollees will delve into the various kinds of healthcare waste and their effects on public and environmental health. The curriculum emphasises infection control, legal statutes, and tailored regional practices, with a strong focus on practical application. Students can complete the programme in a span ranging from six months to two years, with enrolments opening twice annually -- January to June or July to qualify, candidates must have finished Class 12 or an programme leverages a blended learning format, incorporating Self-Instructional Materials (SIMs), live online sessions, instructional videos, and engaging Q&A flexible curriculum lets students choose between a workshop or a project alongside theoretical modules. Evaluation is through assignments and a term-end PROCESS VIA SAMARTHAdmissions for the CHCWM course are currently available. Prospective students can apply through the Samarth portal at Samarth system is a comprehensive digital platform utilised by IGNOU and others to simplify the admissions process, ensuring a smooth user the Samarth portal, applicants can complete registration, submit application forms, upload necessary documents, and settle fees -- all system supports application tracking and provides automated updates on application status and necessary steps, making the admissions process seamless across IGNOU's various the CHCWM programme, IGNOU has also unveiled its inaugural master's programme in Home Science, reflecting its dedication to broadening educational avenues across different fields.
Economic Times
2 hours ago
- Economic Times
New Covid variant 'Nimbus': Symptoms, vaccine response, and why it causes painful 'razor blade throat'
New Covid variant Nimbus symptoms: A new Covid-19 variant, NB.1.8.1, nicknamed "Nimbus," is spreading globally, including in the US and Asia. While more transmissible, it doesn't appear more dangerous. A key symptom is a severe sore throat, described as "razor blade throat," alongside typical symptoms like congestion, fatigue, and fever. Tired of too many ads? Remove Ads What Is the New Covid Variant Nimbus Symptom? New Covid Variant Nimbus: What Are Other Symptoms? Nasal congestion or a runny nose Fatigue Mild cough Fever Muscle or body aches Headaches Diarrhoea Nausea or vomiting Loss of taste or smell Shortness of breath New Covid Variant Nimbus: How Is It Different? Tired of too many ads? Remove Ads New Covid Variant Nimbus: Should You Be Worried? Spread across regions and airports New Covid Variant Nimbus: What WHO is saying? New Covid Variant Nimbus Vaccines ( Originally published on Jun 18, 2025 ) A new Covid-19 variant known as NB.1.8.1, or informally 'Nimbus,' is spreading across parts of the United States and Asia. The World Health Organization (WHO) said on May 28 that the rise in cases has been seen mainly in the eastern Mediterranean, Southeast Asia, and western Pacific regions. While the variant is believed to spread more easily, it does not appear to cause more severe illness compared to previous of the most talked-about symptoms of the Nimbus variant is a very painful sore throat, often called " razor blade throat ". People have described the feeling as similar to swallowing glass or razor blades. Reports suggest that this symptom appears to be more intense than those caused by earlier variantsPeople infected with the Nimbus variant have also reported the following symptoms:Less commonly, some patients are also experiencing:Doctors say that the main difference with this variant is the severity of the sore throat. While past variants also caused throat pain, this one seems to cause more intense discomfort. The sore throat comes from irritation caused by infection in the throat's many experts believe the overall set of symptoms still matches those of previous Covid-19 far, there is no strong evidence that Nimbus leads to more serious illness. But those who are unvaccinated or immunocompromised might still face higher risks, especially for breathing variant made up nearly 11% of globally sequenced samples by mid-May, according to WHO. U.S. airport screenings detected the variant in travellers arriving from affected regions into California, Washington, Virginia, and New WHO has said that although some western Pacific countries have reported more Covid cases and hospitalizations, there is no current evidence showing that the Nimbus variant causes more severe WHO has classified Nimbus as a 'variant under monitoring' and stated that it poses a low risk to global public health. Existing Covid-19 vaccines are expected to remain effective against Secretary Robert F. Kennedy Jr. said last month that Covid-19 shots are no longer recommended for healthy children and pregnant women. The announcement was immediately questioned by several public health experts.(Inputs from agencies)
